Skip Nav Destination
About the Journal
Molecular Cancer Therapeutics publishes articles on the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug action, mechanism of drug resistance, biomarkers of drug response, novel models and technologies, and occasional drug toxicity mechanisms.. Read More About the Journal
Impact Factor
6.009
Featured Articles
Targeting Senescence as a Therapeutic Opportunity for Triple-Negative Breast Cancer
Bruno de Paula, et al.
Trending - Altmetric
Read the article titled, The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth
Last mentioned on Thursday June 1 2023
Read the article titled, Ponatinib (AP24534), a Multitargeted Pan-FGFR Inhibitor with Activity in Multiple FGFR-Amplified or Mutated Cancer Models
Last mentioned on Thursday June 1 2023
Read the article titled, IMiDs Augment CD3-Bispecific Antibody–Induced CD8+ T-Cell Cytotoxicity and Expansion by Enhancing IL2 Production
Last mentioned on Wednesday May 31 2023
Read the article titled, Predicting the Abscopal Effect: Associated Tumor Histologic Subtypes and Biomarkers.
Last mentioned on Thursday June 1 2023